sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


COVID-19 Impact on Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026

COVID-19 Impact on Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026

Category : Pharmaceuticals and Healthcare QY Research Pages :128
Published Date : 2020-09-16

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Squamous Non-Small Cell Lung Cancer Therapeutics Market with our analysts monitoring the situation across the globe.
This report focuses on the global Squamous Non-Small Cell Lung Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Squamous Non-Small Cell Lung Cancer Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Ascenta Therapeutics, Inc. AstraZeneca Plc AVEO Pharmaceuticals, Inc. Bayer AG BIND Therapeutics, Inc. Boehringer Ingelheim GmbH Bristol-Myers Squibb Company Eli Lilly and Company F. Hoffmann-La Roche Ltd. Five Prime Therapeutics, Inc. Genentech, Inc. Incyte Corporation Johnson & Johnson MacroGenics, Inc. Novartis AG Oncogenex Pharmaceuticals, Inc. PsiOxus Therapeutics Limited Market segment by Type, the product can be split into BMS-906024 Buparlisib Hydrochloride FP-1039 Ipilimumab JNJ-42756493 Lenvatinib Others Market segment by Application, split into Research Center Hospital Clinic Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Squamous Non-Small Cell Lung Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. To present the Squamous Non-Small Cell Lung Cancer Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions. In this study, the years considered to estimate the market size of Squamous Non-Small Cell Lung Cancer Therapeutics are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue 1.4 Market Analysis by Type 1.4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 BMS-906024 1.4.3 Buparlisib Hydrochloride 1.4.4 FP-1039 1.4.5 Ipilimumab 1.4.6 JNJ-42756493 1.4.7 Lenvatinib 1.4.8 Others 1.5 Market by Application 1.5.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application: 2020 VS 2026 1.5.2 Research Center 1.5.3 Hospital 1.5.4 Clinic 1.6 Coronavirus Disease 2019 (Covid-19): Squamous Non-Small Cell Lung Cancer Therapeutics Industry Impact 1.6.1 How the Covid-19 is Affecting the Squamous Non-Small Cell Lung Cancer Therapeutics Industry 1.6.1.1 Squamous Non-Small Cell Lung Cancer Therapeutics Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Squamous Non-Small Cell Lung Cancer Therapeutics Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Squamous Non-Small Cell Lung Cancer Therapeutics Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Perspective (2015-2026) 2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Growth Trends by Regions 2.2.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Squamous Non-Small Cell Lung Cancer Therapeutics Historic Market Share by Regions (2015-2020) 2.2.3 Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Squamous Non-Small Cell Lung Cancer Therapeutics Market Growth Strategy 2.3.6 Primary Interviews with Key Squamous Non-Small Cell Lung Cancer Therapeutics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Market Size 3.1.1 Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Revenue (2015-2020) 3.1.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Players (2015-2020) 3.1.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Concentration Ratio 3.2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in 2019 3.3 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players Head office and Area Served 3.4 Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Product Solution and Service 3.5 Date of Enter into Squamous Non-Small Cell Lung Cancer Therapeutics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Historic Market Size by Type (2015-2020) 4.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2021-2026) 5 Squamous Non-Small Cell Lung Cancer Therapeutics Breakdown Data by Application (2015-2026) 5.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) 5.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2015-2020) 6.2 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players in North America (2019-2020) 6.3 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) 6.4 North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2015-2020) 7.2 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players in Europe (2019-2020) 7.3 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) 7.4 Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) 8 China 8.1 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2015-2020) 8.2 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players in China (2019-2020) 8.3 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) 8.4 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) 9 Japan 9.1 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2015-2020) 9.2 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players in Japan (2019-2020) 9.3 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) 9.4 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2015-2020) 10.2 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) 10.4 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) 11 India 11.1 India Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2015-2020) 11.2 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players in India (2019-2020) 11.3 India Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) 11.4 India Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size (2015-2020) 12.2 Squamous Non-Small Cell Lung Cancer Therapeutics Key Players in Central & South America (2019-2020) 12.3 Central & South America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) 12.4 Central & South America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Ascenta Therapeutics, Inc. 13.1.1 Ascenta Therapeutics, Inc. Company Details 13.1.2 Ascenta Therapeutics, Inc. Business Overview and Its Total Revenue 13.1.3 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 13.1.4 Ascenta Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020)) 13.1.5 Ascenta Therapeutics, Inc. Recent Development 13.2 AstraZeneca Plc 13.2.1 AstraZeneca Plc Company Details 13.2.2 AstraZeneca Plc Business Overview and Its Total Revenue 13.2.3 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 13.2.4 AstraZeneca Plc Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) 13.2.5 AstraZeneca Plc Recent Development 13.3 AVEO Pharmaceuticals, Inc. 13.3.1 AVEO Pharmaceuticals, Inc. Company Details 13.3.2 AVEO Pharmaceuticals, Inc. Business Overview and Its Total Revenue 13.3.3 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 13.3.4 AVEO Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) 13.3.5 AVEO Pharmaceuticals, Inc. Recent Development 13.4 Bayer AG 13.4.1 Bayer AG Company Details 13.4.2 Bayer AG Business Overview and Its Total Revenue 13.4.3 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 13.4.4 Bayer AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) 13.4.5 Bayer AG Recent Development 13.5 BIND Therapeutics, Inc. 13.5.1 BIND Therapeutics, Inc. Company Details 13.5.2 BIND Therapeutics, Inc. Business Overview and Its Total Revenue 13.5.3 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 13.5.4 BIND Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) 13.5.5 BIND Therapeutics, Inc. Recent Development 13.6 Boehringer Ingelheim GmbH 13.6.1 Boehringer Ingelheim GmbH Company Details 13.6.2 Boehringer Ingelheim GmbH Business Overview and Its Total Revenue 13.6.3 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 13.6.4 Boehringer Ingelheim GmbH Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) 13.6.5 Boehringer Ingelheim GmbH Recent Development 13.7 Bristol-Myers Squibb Company 13.7.1 Bristol-Myers Squibb Company Company Details 13.7.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue 13.7.3 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 13.7.4 Bristol-Myers Squibb Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) 13.7.5 Bristol-Myers Squibb Company Recent Development 13.8 Eli Lilly and Company 13.8.1 Eli Lilly and Company Company Details 13.8.2 Eli Lilly and Company Business Overview and Its Total Revenue 13.8.3 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 13.8.4 Eli Lilly and Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) 13.8.5 Eli Lilly and Company Recent Development 13.9 F. Hoffmann-La Roche Ltd. 13.9.1 F. Hoffmann-La Roche Ltd. Company Details 13.9.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue 13.9.3 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 13.9.4 F. Hoffmann-La Roche Ltd. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) 13.9.5 F. Hoffmann-La Roche Ltd. Recent Development 13.10 Five Prime Therapeutics, Inc. 13.10.1 Five Prime Therapeutics, Inc. Company Details 13.10.2 Five Prime Therapeutics, Inc. Business Overview and Its Total Revenue 13.10.3 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 13.10.4 Five Prime Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) 13.10.5 Five Prime Therapeutics, Inc. Recent Development 13.11 Genentech, Inc. 10.11.1 Genentech, Inc. Company Details 10.11.2 Genentech, Inc. Business Overview and Its Total Revenue 10.11.3 Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 10.11.4 Genentech, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) 10.11.5 Genentech, Inc. Recent Development 13.12 Incyte Corporation 10.12.1 Incyte Corporation Company Details 10.12.2 Incyte Corporation Business Overview and Its Total Revenue 10.12.3 Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 10.12.4 Incyte Corporation Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) 10.12.5 Incyte Corporation Recent Development 13.13 Johnson & Johnson 10.13.1 Johnson & Johnson Company Details 10.13.2 Johnson & Johnson Business Overview and Its Total Revenue 10.13.3 Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 10.13.4 Johnson & Johnson Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) 10.13.5 Johnson & Johnson Recent Development 13.14 MacroGenics, Inc. 10.14.1 MacroGenics, Inc. Company Details 10.14.2 MacroGenics, Inc. Business Overview and Its Total Revenue 10.14.3 MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 10.14.4 MacroGenics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) 10.14.5 MacroGenics, Inc. Recent Development 13.15 Novartis AG 10.15.1 Novartis AG Company Details 10.15.2 Novartis AG Business Overview and Its Total Revenue 10.15.3 Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 10.15.4 Novartis AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) 10.15.5 Novartis AG Recent Development 13.16 Oncogenex Pharmaceuticals, Inc. 10.16.1 Oncogenex Pharmaceuticals, Inc. Company Details 10.16.2 Oncogenex Pharmaceuticals, Inc. Business Overview and Its Total Revenue 10.16.3 Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 10.16.4 Oncogenex Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) 10.16.5 Oncogenex Pharmaceuticals, Inc. Recent Development 13.17 PsiOxus Therapeutics Limited 10.17.1 PsiOxus Therapeutics Limited Company Details 10.17.2 PsiOxus Therapeutics Limited Business Overview and Its Total Revenue 10.17.3 PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Introduction 10.17.4 PsiOxus Therapeutics Limited Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) 10.17.5 PsiOxus Therapeutics Limited Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

Get Free Sample

List of Tables Table 1. Squamous Non-Small Cell Lung Cancer Therapeutics Key Market Segments Table 2. Key Players Covered: Ranking by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Table 3. Ranking of Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of BMS-906024 Table 6. Key Players of Buparlisib Hydrochloride Table 7. Key Players of FP-1039 Table 8. Key Players of Ipilimumab Table 9. Key Players of JNJ-42756493 Table 10. Key Players of Lenvatinib Table 11. Key Players of Others Table 12. COVID-19 Impact Global Market: (Four Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Forecast Scenarios) Table 13. Opportunities and Trends for Squamous Non-Small Cell Lung Cancer Therapeutics Players in the COVID-19 Landscape Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 15. Key Regions/Countries Measures against Covid-19 Impact Table 16. Proposal for Squamous Non-Small Cell Lung Cancer Therapeutics Players to Combat Covid-19 Impact Table 17. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 18. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 19. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 20. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Regions (2015-2020) Table 21. Global Squamous Non-Small Cell Lung Cancer Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 22. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Regions (2021-2026) Table 23. Market Top Trends Table 24. Key Drivers: Impact Analysis Table 25. Key Challenges Table 26. Squamous Non-Small Cell Lung Cancer Therapeutics Market Growth Strategy Table 27. Main Points Interviewed from Key Squamous Non-Small Cell Lung Cancer Therapeutics Players Table 28. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue by Players (2015-2020) (Million US$) Table 29. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Players (2015-2020) Table 30. Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics as of 2019) Table 31. Global Squamous Non-Small Cell Lung Cancer Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 32. Key Players Headquarters and Area Served Table 33. Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Product Solution and Service Table 34. Date of Enter into Squamous Non-Small Cell Lung Cancer Therapeutics Market Table 35. Mergers & Acquisitions, Expansion Plans Table 36. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 37. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Share by Type (2015-2020) Table 38. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2021-2026) Table 39. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Share by Application (2015-2020) Table 40. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 41. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Share by Application (2021-2026) Table 42. North America Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 43. North America Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Market Share (2019-2020) Table 44. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 45. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2015-2020) Table 46. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 47. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2015-2020) Table 48. Europe Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 49. Europe Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Market Share (2019-2020) Table 50. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 51. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2015-2020) Table 52. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 53. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2015-2020) Table 54. China Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 55. China Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Market Share (2019-2020) Table 56. China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 57. China Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2015-2020) Table 58. China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 59. China Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2015-2020) Table 60. Japan Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 61. Japan Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Market Share (2019-2020) Table 62. Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 63. Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2015-2020) Table 64. Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 65. Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2015-2020) Table 66. Southeast Asia Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 67. Southeast Asia Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Market Share (2019-2020) Table 68. Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 69. Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2015-2020) Table 70. Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 71. Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2015-2020) Table 72. India Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 73. India Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Market Share (2019-2020) Table 74. India Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 75. India Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2015-2020) Table 76. India Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 77. India Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2015-2020) Table 78. Central & South America Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 79. Central & South America Key Players Squamous Non-Small Cell Lung Cancer Therapeutics Market Share (2019-2020) Table 80. Central & South America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 81. Central & South America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type (2015-2020) Table 82. Central & South America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 83. Central & South America Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application (2015-2020) Table 84. Ascenta Therapeutics, Inc. Company Details Table 85. Ascenta Therapeutics, Inc. Business Overview Table 86. Ascenta Therapeutics, Inc. Product Table 87. Ascenta Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 88. Ascenta Therapeutics, Inc. Recent Development Table 89. AstraZeneca Plc Company Details Table 90. AstraZeneca Plc Business Overview Table 91. AstraZeneca Plc Product Table 92. AstraZeneca Plc Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 93. AstraZeneca Plc Recent Development Table 94. AVEO Pharmaceuticals, Inc. Company Details Table 95. AVEO Pharmaceuticals, Inc. Business Overview Table 96. AVEO Pharmaceuticals, Inc. Product Table 97. AVEO Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 98. AVEO Pharmaceuticals, Inc. Recent Development Table 99. Bayer AG Company Details Table 100. Bayer AG Business Overview Table 101. Bayer AG Product Table 102. Bayer AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 103. Bayer AG Recent Development Table 104. BIND Therapeutics, Inc. Company Details Table 105. BIND Therapeutics, Inc. Business Overview Table 106. BIND Therapeutics, Inc. Product Table 107. BIND Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 108. BIND Therapeutics, Inc. Recent Development Table 109. Boehringer Ingelheim GmbH Company Details Table 110. Boehringer Ingelheim GmbH Business Overview Table 111. Boehringer Ingelheim GmbH Product Table 112. Boehringer Ingelheim GmbH Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 113. Boehringer Ingelheim GmbH Recent Development Table 114. Bristol-Myers Squibb Company Company Details Table 115. Bristol-Myers Squibb Company Business Overview Table 116. Bristol-Myers Squibb Company Product Table 117. Bristol-Myers Squibb Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 118. Bristol-Myers Squibb Company Recent Development Table 119. Eli Lilly and Company Business Overview Table 120. Eli Lilly and Company Product Table 121. Eli Lilly and Company Company Details Table 122. Eli Lilly and Company Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 123. Eli Lilly and Company Recent Development Table 124. F. Hoffmann-La Roche Ltd. Company Details Table 125. F. Hoffmann-La Roche Ltd. Business Overview Table 126. F. Hoffmann-La Roche Ltd. Product Table 127. F. Hoffmann-La Roche Ltd. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 128. F. Hoffmann-La Roche Ltd. Recent Development Table 129. Five Prime Therapeutics, Inc. Company Details Table 130. Five Prime Therapeutics, Inc. Business Overview Table 131. Five Prime Therapeutics, Inc. Product Table 132. Five Prime Therapeutics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 133. Five Prime Therapeutics, Inc. Recent Development Table 134. Genentech, Inc. Company Details Table 135. Genentech, Inc. Business Overview Table 136. Genentech, Inc. Product Table 137. Genentech, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 138. Genentech, Inc. Recent Development Table 139. Incyte Corporation Company Details Table 140. Incyte Corporation Business Overview Table 141. Incyte Corporation Product Table 142. Incyte Corporation Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 143. Incyte Corporation Recent Development Table 144. Johnson & Johnson Company Details Table 145. Johnson & Johnson Business Overview Table 146. Johnson & Johnson Product Table 147. Johnson & Johnson Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 148. Johnson & Johnson Recent Development Table 149. MacroGenics, Inc. Company Details Table 150. MacroGenics, Inc. Business Overview Table 151. MacroGenics, Inc. Product Table 152. MacroGenics, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 153. MacroGenics, Inc. Recent Development Table 154. Novartis AG Company Details Table 155. Novartis AG Business Overview Table 156. Novartis AG Product Table 157. Novartis AG Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 158. Novartis AG Recent Development Table 159. Oncogenex Pharmaceuticals, Inc. Company Details Table 160. Oncogenex Pharmaceuticals, Inc. Business Overview Table 161. Oncogenex Pharmaceuticals, Inc. Product Table 162. Oncogenex Pharmaceuticals, Inc. Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 163. Oncogenex Pharmaceuticals, Inc. Recent Development Table 164. PsiOxus Therapeutics Limited Company Details Table 165. PsiOxus Therapeutics Limited Business Overview Table 166. PsiOxus Therapeutics Limited Product Table 167. PsiOxus Therapeutics Limited Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) (Million US$) Table 168. PsiOxus Therapeutics Limited Recent Development Table 169. Research Programs/Design for This Report Table 170. Key Data Information from Secondary Sources Table 171. Key Data Information from Primary Sources List of Figures Figure 1. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. BMS-906024 Features Figure 3. Buparlisib Hydrochloride Features Figure 4. FP-1039 Features Figure 5. Ipilimumab Features Figure 6. JNJ-42756493 Features Figure 7. Lenvatinib Features Figure 8. Others Features Figure 9. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Application: 2020 VS 2026 Figure 10. Research Center Case Studies Figure 11. Hospital Case Studies Figure 12. Clinic Case Studies Figure 13. Squamous Non-Small Cell Lung Cancer Therapeutics Report Years Considered Figure 14. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth 2015-2026 (US$ Million) Figure 15. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Regions: 2020 VS 2026 Figure 16. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Regions (2021-2026) Figure 17. Porter's Five Forces Analysis Figure 18. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Share by Players in 2019 Figure 19. Global Top Squamous Non-Small Cell Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Squamous Non-Small Cell Lung Cancer Therapeutics as of 2019 Figure 20. The Top 10 and 5 Players Market Share by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in 2019 Figure 21. North America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Europe Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 23. China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 26. India Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 27. Central & South America Squamous Non-Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 28. Ascenta Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Ascenta Therapeutics, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 30. AstraZeneca Plc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. AstraZeneca Plc Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 32. AVEO Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. AVEO Pharmaceuticals, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 34. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Bayer AG Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 36. BIND Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. BIND Therapeutics, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 38. Boehringer Ingelheim GmbH Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Boehringer Ingelheim GmbH Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 40. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Bristol-Myers Squibb Company Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 42. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Eli Lilly and Company Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 44. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 46. Five Prime Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. Five Prime Therapeutics, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 48. Genentech, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. Genentech, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 50. Incyte Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 51. Incyte Corporation Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 52. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 53. Johnson & Johnson Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 54. MacroGenics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 55. MacroGenics, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 56. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 57. Novartis AG Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 58. Oncogenex Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 59. Oncogenex Pharmaceuticals, Inc. Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 60. PsiOxus Therapeutics Limited Total Revenue (US$ Million): 2019 Compared with 2018 Figure 61. PsiOxus Therapeutics Limited Revenue Growth Rate in Squamous Non-Small Cell Lung Cancer Therapeutics Business (2015-2020) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed

Get Free Sample

Related Reports

COVID-19 Impact on Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

COVID-19 Impact on Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

COVID-19 Impact on Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

COVID-19 Impact on Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

COVID-19 Impact on Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)